Renal disease and left atrial remodeling predict atrial fibrillation in patients with cardiovascular risk factors

被引:26
|
作者
Sciacqua, Angela [1 ]
Perticone, Maria
Tripepi, Giovanni [2 ]
Miceli, Sofia [1 ]
Tassone, Eliezer J. [1 ]
Grillo, Nadia [1 ]
Carullo, Giuseppe [1 ]
Sesti, Giorgio [1 ]
Perticone, Francesco [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, I-88100 Catanzaro, Italy
[2] CNR, Inst Biomed, Clin Epidemiol & Physiopathol Renal Dis & Hyperte, Reggio Di Calabria, Italy
关键词
Atrial fibrillation; Chronic kidney disease; Atrial volume; Left ventricular hypertrophy; LEFT-VENTRICULAR HYPERTROPHY; KIDNEY-FUNCTION; CARDIAC MASS; HEART; DYSFUNCTION; ECHOCARDIOGRAPHY; HYPERTENSION; CREATININE; OUTCOMES; VOLUME;
D O I
10.1016/j.ijcard.2014.04.259
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: In this prospective population-based study, we tested the possible interaction between chronic kidney disease (CKD) and left atrium volume index (LAVI) in predicting incident atrial fibrillation (AF). Methods: We enrolled 3549 Caucasian subjects, 1829 men and 1720 women, aged 60.7 +/- 10.6 years, without baseline AF and thyroid disorders. Echocardiographic left ventricular mass and LAVI were measured. Renal function was calculated by estimated glomerular filtration rate (e-GFR). To test the effect of some clinical confounders on incident AF, we constructed different models including clinical and laboratory parameters. AF diagnosis was made by standard electrocardiogram or 24-h ECG-Holter, hospital discharge diagnoses, and by the all-clinical documentation. Results: During the follow-up (53.3 +/- 18.1 months), 546 subjects developed AF (4.5 events/100 patient-years). Progressors to AF were older, had a higher body mass index, blood pressure, LDL-cholesterol, glucose, cardiac mass, and LAVI, and had lower e-GFR. Hypertension, metabolic syndrome, diabetes, cardiac hypertrophy and CKD were more common among AF cases than controls. In the final Cox regression model, variables that remained significantly associated with AF were: cardiac hypertrophy (HR = 1.495, 95% CI = 1.215-1.841), renal disease (HR = 1.528, 95% CI = 1.261-1.851), age (HR = 1.586, 95% CI = 1.461-1.725) and LAVI (HR = 2.920, 95% CI = 2.426-3.515). The interaction analysis demonstrated a synergic effect between CKD and cardiac hypertrophy (HR = 4.040, 95% CI = 2.661-6.133), as well as between CKD and LAVI (HR = 4.875, 95% CI = 2.699-8.805). The coexistence of all three subclinical organ damages significantly increases the arrhythmic risk (HR = 7.185, 95% CI = 5.041-10.240). Conclusions: Our data demonstrate that LAVI and CKD significantly interact in a synergic manner in increasing AF risk. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 50 条
  • [1] Left Atrial Remodeling and Thromboembolic Risk in Patients With Recurrent Atrial Fibrillation
    Shavarov, A. A.
    Yusupov, A. A.
    Kiyakbaev, G. K.
    Vasyuk, Y. A.
    Moiseev, V. S.
    [J]. KARDIOLOGIYA, 2015, 55 (11) : 37 - 44
  • [2] Atrial remodeling and atrial fibrillation in acquired forms of cardiovascular disease
    Jansen, Hailey J.
    Bohne, Loryn J.
    Gillis, Anne M.
    Rose, Robert A.
    [J]. HEART RHYTHM O2, 2020, 1 (02): : 147 - 159
  • [3] Use of a Genetic Risk Score to Predict Atrial Fibrillation in Patients With Cardiovascular Disease
    Garfinkel, Amanda C.
    Marston, Nicholas A.
    Kamanu, Frederick K.
    Melloni, Giorgio M.
    Roselli, Carolina
    Bhatt, Deepak L.
    Bonaca, Marc P.
    Cannon, Christopher P.
    Giugliano, Robert P.
    Odonoghue, Michelle L.
    Raz, Itamar
    Scirica, Benjamin M.
    Braunwald, Eugene
    Ellinor, Patrick T.
    Lubitz, Steven A.
    Sabatine, Marc S.
    Ruff, Christian T.
    [J]. CIRCULATION, 2021, 144
  • [4] Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation
    King, Jordan B.
    Azadani, Peyman N.
    Suksaranjit, Promporn
    Bress, Adam P.
    Witt, Daniel M.
    Han, Frederick T.
    Chelu, Mihail G.
    Silver, Michelle A.
    Biskupiak, Joseph
    Wilson, Brent D.
    Morris, Alan K.
    Kholmovski, Eugene G.
    Marrouche, Nassir
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (11) : 1311 - 1321
  • [5] Morphologic remodeling of left atrial appendage in patients with atrial fibrillation
    Kishima, Hideyuki
    Mine, Takanao
    Takahashi, Satoshi
    Ashida, Kenki
    Ishihara, Masaharu
    Masuyama, Tohru
    [J]. HEART RHYTHM, 2016, 13 (09) : 1823 - 1828
  • [6] Left Atrial Appendage Dimensions Predict the Risk of Stroke/TIA in Patients With Atrial Fibrillation
    Beinart, Roy
    Heist, E. Kevin
    Newell, John B.
    Holmvang, Godtfred
    Ruskin, Jeremy N.
    Mansour, Moussa
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2011, 22 (01) : 10 - 15
  • [7] ATRIAL FIBRILLATION Atrial fibrillation and rheumatoid arthritis are cardiovascular risk factors
    Hippisley-Cox, Julia
    Coupland, Carol
    Robson, John
    Brindle, Peter
    [J]. BRITISH MEDICAL JOURNAL, 2012, 344
  • [8] Left atrial anatomic remodeling in atrial fibrillation
    Cosio, Francisco G.
    Castillo, Ernesto
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 (01) : 53 - 54
  • [9] Left atrial appendage closure devices for cardiovascular risk reduction in atrial fibrillation patients
    Cruz-Gonzalez, Ignacio
    Carlos Rama-Merchan, Juan
    Rodriguez-Collado, Javier
    Martin-Moreiras, Javier
    Diego-Nieto, Alejandro
    Arribas-Jimenez, Antonio
    Luis Sanchez, Pedro
    [J]. RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2015, 6 : 47 - 56
  • [10] Effects of probucol on left atrial remodeling in patients with paroxysmal atrial fibrillation
    Shao, Qingmiao
    Korantzopoulos, Panagiotis
    Fu, Huaying
    Ye, Lan
    Liu, Enzhao
    Xu, Gang
    Li, Guangping
    Liu, Tong
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 207 : 117 - 119